People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina has appointed Elizabeth Brady to be VP of global supply chain and Emily Winn-Deen to be VP of diagnostics development.

Brady, who formerly was a VP at Boston Scientific, will run global sourcing, planning, logistics, and distribution operations. Winn-Deen previously was VP of Genetics and Oncology R&D at Cepheid, and she was involved in diagnostics at Roche Molecular Systems, Applera, Oncor, and Bayer Diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.